Journal Article FZJ-2019-04531

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
The tetrahydroxanthone-dimer phomoxanthone A is a strong inducer of apoptosis in cisplatin-resistant solid cancer cells

 ;  ;  ;  ;  ;  ;  ;

2019
Elsevier Amsterdam [u.a.]

Bioorganic & medicinal chemistry 27(19), 115044 () [10.1016/j.bmc.2019.115044]

This record in other databases:      

Please use a persistent id in citations: doi:

Abstract: Platinum compounds are the first-line therapy for many types of cancer. However, drug resistance has frequently been reported for and is a major limitation of platinum-based chemotherapy in the clinic. In the current study, we examined the anti-tumor activity of phomoxanthone A (PXA), a tetrahydroxanthone dimer isolated from the endophytic fungus Phomopsis longicolla, in several solid cancer cell lines and their cisplatin-resistant sub-cell lines. PXA showed strong cytotoxic effects with IC50 values in the high nanomolar or low micromolar range in MTT assays. IC50 values of PXA were lower than those of cisplatin. Remarkably, equipotent anti-cancer activity was found in cisplatin-sensitive and respective cisplatin-resistant cells. Anticancer effects of PXA were studied in further detail in ovarian cancer (A2780) and bladder cancer (J82) cell pairs. PXA led to rapid depolarization of the mitochondrial membrane potential and strong activation of caspase 3 and 7, eventually resulting in strong induction of apoptosis. These effects occurred again both in sensitive and resistant cell lines. IC50 values of PXA from MTT and mitochondrial membrane depolarization assays were in good agreement. Configurational free energy computations indicate that both the neutral and singly negatively charged PXA show membrane partitioning and can penetrate the inner mitochondrial membrane. PXA treatment did not damage the plasma membranes of cancer cells, thus excluding unspecific membrane effects. Further, PXA had neither an effect on intracellular ROS nor on reduction of ROS after hydrogen peroxide treatment. In conclusion, our studies present PXA as a natural compound with strong apoptotic anticancer effects against platinum-resistant solid cancers. This may open new treatment options in clinically resistant malignancies.

Classification:

Contributing Institute(s):
  1. Jülich Supercomputing Center (JSC)
  2. John von Neumann - Institut für Computing (NIC)
  3. Strukturbiochemie (ICS-6)
Research Program(s):
  1. 511 - Computational Science and Mathematical Methods (POF3-511) (POF3-511)
  2. Forschergruppe Gohlke (hkf7_20170501) (hkf7_20170501)

Appears in the scientific report 2019
Database coverage:
Medline ; BIOSIS Previews ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; Ebsco Academic Search ; IF < 5 ; JCR ; NCBI Molecular Biology Database ; NationallizenzNationallizenz ; SCOPUS ; Science Citation Index ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Dokumenttypen > Aufsätze > Zeitschriftenaufsätze
Institutssammlungen > IBI > IBI-7
Workflowsammlungen > Öffentliche Einträge
Institutssammlungen > JSC
ICS > ICS-6
Publikationsdatenbank
NIC

 Datensatz erzeugt am 2019-09-03, letzte Änderung am 2021-01-30



Dieses Dokument bewerten:

Rate this document:
1
2
3
 
(Bisher nicht rezensiert)